Medicine and Dentistry
Inflammatory Bowel Disease
100%
Pediatrics
64%
Calgranulin
38%
Faecal Calprotectin
38%
Crohn's Disease
25%
Randomized Controlled Trial
24%
Endoscopy
18%
Disease
18%
Diarrhea
17%
Symptom
15%
Primary Health Care
14%
Adolescent
14%
Liver Transplantation
14%
Diagnosis
13%
Cohort Analysis
12%
Infliximab
11%
Anemia
11%
Patient with Inflammatory Bowel Disease
11%
Childbirth
11%
Hypochromic Anemia
10%
Diagnostic Accuracy
10%
Systematic Review
9%
Abdominal Pain
9%
Calgranulin C
9%
Malnutrition
9%
Gastrointestinal Distress
9%
Colitis
9%
Patient Referral
8%
Adverse Event
8%
Umbilical Cord
7%
Meta-Analysis
7%
Ulcerative Colitis
7%
Enzyme Linked Immunosorbent Assay
6%
Disease Activity
6%
Odds Ratio
6%
Retrospective Cohort Study
6%
Quality of Life
6%
Stool Test
6%
Surgery
6%
Maintenance Therapy
5%
Immunomodulating Agent
5%
Pediatrician
5%
Feces
5%
Bilirubin
5%
Pharmacology, Toxicology and Pharmaceutical Science
Inflammatory Bowel Disease
36%
Crohn's Disease
33%
Infliximab
32%
Remission
24%
Anemia
13%
Randomized Controlled Trial
12%
Calgranulin
9%
Cohort Study
9%
Disease Activity
9%
Disease
8%
Trough Level
7%
Adverse Event
6%
Tumor Necrosis Factor Inhibitor
6%
Marasmus
6%
Kwashiorkor
6%
Iron Deficiency Anemia
6%
Ustekinumab
6%
Malnutrition
6%
Diarrhea
6%
Toxic Injury
6%
Pharmacokinetics
6%
Enzyme-Linked Immunosorbent Assay
6%
Immunomodulating Agent
5%
Adalimumab
5%
Tumor Necrosis Factor
5%
Monotherapy
5%
Keyphrases
Inflammatory Bowel Disease
38%
Crohn's Disease
19%
Fecal Calprotectin
16%
Infliximab
14%
Pediatric Inflammatory Bowel Disease
12%
Calprotectin
12%
Crohn's
9%
Colitis
9%
Primary Care
7%
Gastrointestinal Diseases
7%
Remission
7%
Randomized Controlled Trial
6%
Calgranulin C
6%
Severe Malnutrition
6%
Waitlist Mortality
6%
Conventional Treatment
6%
Anti-tumor Necrosis Factor (anti-TNF)
5%
Clinical Remission
5%
